好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Caregiver burden and soluble urokinase-type plasminogen activator receptor (SuPAR) levels in healthy volunteers
Neuromuscular and Clinical Neurophysiology (EMG)
P4 - Poster Session 4 (8:00 AM-9:00 AM)
11-006

The objective is to investigate the association between caregiver burden and the biomarker, soluble urokinase-type plasminogen activator receptor (SuPAR), in healthy volunteers.

Previous studies have reported elevated serum levels of inflammatory markers in caregivers for individuals with neurologic illness. Additionally, SuPAR, a biomarker of systemic inflammation, has been associated with increased morbidity and mortality. The relationship between caregiver burden and SuPAR levels has not yet been explored.

Healthy volunteers were recruited from Rush University Movement Disorder Clinic in an observational cohort study assessing serum immune biomarkers. Caregiver status and burden was assessed using a Short Form Zarit Burden Interview (ZBI-12). For continuous variables, we used a T-test for normally distributed data and a Wilcoxon rank-sum test if not. For categorical variables, we used Chi-squared test or Fisher’s exact test.

Primary and non-primary caregivers were similar in mean age (60.9 vs 64.3 years respectively, p=0.3).  Primary caregivers were 57.14% female vs. 36.6% female in the non-primary caregiver cohort (p=0.26). Groups were similar in education (p=0.43), race (p=1.0), ethnicity (p=0.34), smoking history (p=0.91), smoking status (p=1.0), and rates of family history of autoimmune disease or neurological disease (p= 0.45, and 0.14 respectively). Primary caregivers had elevated SuPAR compared to non-primary caregivers (3.73 vs. 2.72 ng/mL, p=0.01). Primary caregivers also exhibited significantly higher ZBI-12 scores in comparison to non-primary caregivers (18.57 vs. 5.4, p < 0.0001). There was a trend to a positive correlation between SuPAR and ZBI-12 in primary caregivers, though this was not significant (correlation coefficient=0.35, p=0.12).

Healthy volunteers who identified as the primary caretaker of a patient with parkinsonism had elevated SuPAR compared to their healthy non-primary caregiver counterparts. A larger sample size should be used to explore the relationship between SuPAR and other inflammatory markers and caregiver stress in this population.

Authors/Disclosures
Jessica Joyce
PRESENTER
Ms. Joyce has nothing to disclose.
Noel Cabanas No disclosure on file
Rohan Pisharody, MD Mr. Pisharody has nothing to disclose.
Roshni A. Patel, MD (Jesse Brown VA) Dr. Patel has nothing to disclose.
Bichun Ouyang Bichum Ouyang has nothing to disclose.
No disclosure on file
Deborah H. Hall, MD, PhD, FAAN (Rush University) Dr. Hall has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier - Parkinsonism and Related Disorders. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. The institution of Dr. Hall has received research support from Parkinson's Foundation. The institution of Dr. Hall has received research support from CHDI. The institution of Dr. Hall has received research support from Uniqure. The institution of Dr. Hall has received research support from NIH.
Natalie P. Witek, MD (Rush University) Dr. Witek has nothing to disclose.